Vaccinex Inc
General ticker "VCNX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $7.0M
Vaccinex Inc does not follow the US Stock Market performance with the rate: -39.4%.
Estimated limits based on current volatility of 7.6%: low 0.91$, high 1.39$
Factors to consider:
- Current price 83.0% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [7.70$, 30.56$]
- 2024-12-30 to 2025-12-30 estimated range: [4.62$, 15.63$]
Financial Metrics affecting the VCNX estimates:
- Negative: Non-GAAP EPS, $ of -100.87 <= 0.10
- Negative: Operating profit margin, % of -97.57 <= 1.03
- Negative: Operating cash flow per share per price, % of -80 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term VCNX quotes
Long-term VCNX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.90MM | $0.28MM | $0.57MM |
| Operating Expenses | $23.39MM | $20.18MM | $23.45MM |
| Operating Income | $-22.49MM | $-19.91MM | $-22.89MM |
| Non-Operating Income | $0.11MM | $0.09MM | $2.63MM |
| Interest Expense | $0.81MM | $0.00MM | $0.00MM |
| R&D Expense | $17.16MM | $13.98MM | $16.57MM |
| Income(Loss) | $-22.38MM | $-19.82MM | $-20.25MM |
| Profit(Loss) | $-22.38MM | $-19.82MM | $-20.25MM |
| Stockholders Equity | $7.41MM | $5.19MM | $-2.31MM |
| Inventory | $0.00MM | $0.00MM | $0.00MM |
| Assets | $9.84MM | $7.98MM | $3.63MM |
| Operating Cash Flow | $-25.30MM | $-19.07MM | $-17.23MM |
| Capital expenditure | $0.03MM | $0.10MM | $0.07MM |
| Investing Cash Flow | $-0.03MM | $-0.10MM | $-0.07MM |
| Financing Cash Flow | $23.32MM | $16.98MM | $12.45MM |
| Earnings Per Share* | $-170.04 | $-97.59 | $-43.68 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.